Canada is allocating $67 million through its Life Sciences Fund to support five research projects spanning areas like antimicrobial resistance and organ transplantation. This investment signals a strategic move to bolster Canada's position in the rapidly expanding life sciences sector and strengthen its technological independence. Notably, the funded projects have "dual-use" capabilities, meaning they can benefit both civilian healthcare and national defense, potentially impacting areas like blood transfusions and portable dialysis systems.
Read the full article at BetaKit
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



